|
|
News Breaks | | | | February 19, 2013 | | 11:55 EDT |  | PPHM, FE, RIGL, ODP, TMO | High option volume stocks: FE TMO RIGL PPHM ODP
| |
|
News For FE;TMO;RIGL;PPHM;ODP From The Last 14 Days Check below for free stories on FE;TMO;RIGL;PPHM;ODP the last two weeks. |
|
|
| May 23, 2013 | | 05:34 EDT |  | TMO | Thermo Fisher price target raised to $100 from $90 at Mizuho
 Subscribe for More Information | | | May 22, 2013 | | 09:38 EDT |  | TMO | Thermo Fisher provides long-term financial profile
Subscribe for More Information | | | 09:33 EDT |  | TMO | Thermo Fisher reaffirms outlook for 2013 at analyst meeting
Subscribe for More Information | | | 07:34 EDT | | RIGL | Rigel Pharmaceuticals to initiate Phase 2 clinical trial in dry eye
Subscribe for More Information | | | May 21, 2013 | | 20:03 EDT |  | TMO | Roche, Sigma-Aldrich teamed for Life bid, Reuters says
Subscribe for More Information | | | May 20, 2013 | | 08:50 EDT | | PPHM | Peregrine reaches agreement with FDA on Phase 3 trial design for Bavituximab
Peregrine Pharmaceuticals announced that it has reached agreement with the FDA on a Phase III registration trial design of the company's lead clinical immunotherapeutic candidate bavituximab in second-line non-small cell lung cancer. The trial design was supported by promising data from a Phase IIb trial in patients treated with bavituximab plus docetaxel. The Phase III clinical trial will be a randomized, double-blind, placebo-controlled trial evaluating bavituximab plus docetaxel versus docetaxel alone enrolling approximately 600 patients at sites worldwide. The trial will enroll Stage IIIB/IV non-squamous, NSCLC patients who have progressed after standard front-line treatment. The primary endpoint of the trial will be overall survival. | | | 08:40 EDT | | PPHM | Peregrine trading halted, pending news
Subscribe for More Information | | | May 17, 2013 | | 14:57 EDT |  | TMO | Thermo Fisher to host analyst meeting
Subscribe for More Information | | | May 16, 2013 | | 16:37 EDT | | FE | FirstEnergy unit's nuclear power plant returns to service
Subscribe for More Information | | | May 15, 2013 | | 17:26 EDT | | TMO | Third Point gives quarterly update on stakes
NEW STAKES: Virgin Media (VMED), Tiffany (TIF), B/E Aerospace (BEAV), Anadarko (APC), and Thermo Fisher (TMO). INCREASED STAKES: International Paper (IP), Abbvie (ABBV), TransDigm (TDG), Constellation Brands (STZ), and Dollar General (DG). DECREASED STAKES: Delphi (DLPH), Murphy Oil (MUR), AIG (AIG), LyondellBasell (LYB), and Liberty Global (LBTYA). LIQUIDATED STAKES: Tesoro (TSO), Morgan Stanley (MS), Symantec (SYMC), Herbalife (HLF), and Illumina (ILMN). | | | | May 14, 2013 | | 17:48 EDT | | TMO | Lone Pine gives quarterly update on stakes
NEW STAKES: Valeant Pharmaceuticals (VRX), Virgin Media (VMED), Thermo Fisher Scientific (TMO), CME Group (CME), and Liberty Media (LMCA). INCREASED STAKES: Mead Johnson Nutrition (MJN), News Corp (NWSA), Intuitive Surgical (ISRG), Monsanto (MON), and Qualcomm (QCOM). DECREASED STAKES: Cognizant Technology Solutions (CTSH), Equinix (EQIX), Ralph Lauren (RL), Disney (DIS), and Oceaneering International (OII). LIQUIDATED STAKES: Facebook (FB), Crown Castle (CCI), Accretive Health (AH), Informatica (INFA), and NetEase (NTES). | | | 05:44 EDT | | TMO | Banks work deals from both sides of the field, WSJ reports
Subscribe for More Information | | | May 13, 2013 | | 07:20 EDT | | TMO | Thermo Fisher sued over Mexico plant sale used by drug cartel, Reuters reports
Subscribe for More Information | |
|
|
|
|
|
|
